Results for tag: "Multiple System Atrophy Drug"

Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that affects the autonomic nervous system. It is characterized by a combination of motor, autonomic, and cognitive symptoms. Treatment for MSA is largely symptomatic and supportive, and there is currently no cure. The MSA drug market is a small but growing segment of the Central Nervous System (CNS) drug market. It is composed of drugs that are used to treat the symptoms of MSA, such as Parkinsonism, autonomic dysfunction, and cognitive impairment. These drugs include dopaminergic agents, anticholinergics, and cholinesterase inhibitors. The MSA drug market is expected to experience steady growth in the coming years, driven by the increasing prevalence of MSA and the development of new drugs. Some of the major companies in the MSA drug market include AbbVie, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more